
BCS · NYSE
The supplied consensus is Buy across seven analysts, with a mean price target of $32.8. No low or high target is provided, so target clustering and the width of the distribution cannot be established. The mean target is above the stated $28.02 ending price, but the evidence does not identify which named analyst or firm is most bullish or least bullish. The substantive disagreement is between the aggregate Buy view and the Hold downgrade highlighted by Seeking Alpha, which cites unexpected costs and revenue headwinds after the July 28 Q2 update. Revision direction over the past week is not available in aggregate; one TipRanks snippet says a Buy was reaffirmed while its target was trimmed to £6.25, without naming the analyst or firm.